Protocol Ledger

NCT04974008 · Phase II · ACTIVE NOT RECRUITING

Osteosarcoma Maintenance Therapy With OST31-164

Interventional Phase II clinical trial protocol NCT04974008 sponsored by Emerald Clinical in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-10-21 Enrollment: 39 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04974008
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)39 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04974008
Protocol FieldVerified Registry Value
NCT IdentifierNCT04974008
Consolidated Lead SponsorEmerald Clinical
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment39 participants (ACTUAL)
Registered Start Date2021-10-21
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI